Sale!

TPM3 Gene Nemaline Myopathy Type 1 Genetic Test Cost

Name: TPM3 Gene Nemaline Myopathy Type 1 Genetic Test Cost
SKU: TEST-1819
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TPM3 Gene Nemaline Myopathy Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TPM3 gene, which are known to cause Nemaline Myopathy Type 1. This condition is a rare genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle cells, which can affect individuals from infancy or childhood, leading to difficulties in walking, feeding, and breathing. The test involves analyzing the patient’s DNA to detect any abnormalities in the TPM3 gene, providing crucial information for accurate diagnosis, management, and understanding of the disorder’s progression. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology employed to ensure precise and reliable results. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures that patients receive comprehensive support throughout the testing process, from sample collection to result interpretation, aiding in the better management of Nemaline Myopathy Type 1.

Description

TPM3 Gene Nemaline Myopathy Type 1 Genetic Test

Test Name: TPM3 Gene Nemaline Myopathy Type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TPM3 Gene Nemaline Myopathy Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TPM3 Gene Nemaline Myopathy Type 1.

Test Details: The TPM3 gene is associated with nemaline myopathy type 1, which is a rare genetic disorder characterized by muscle weakness and hypotonia (low muscle tone). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the TPM3 gene to identify any mutations or variations that may be causing the condition. NGS genetic testing is a highly accurate and efficient method that can simultaneously analyze multiple genes, including the TPM3 gene, to provide a comprehensive evaluation of the genetic basis of nemaline myopathy type 1. This type of testing can help confirm a diagnosis, identify specific genetic mutations, and inform treatment and management options. It is important to consult with a genetic counselor or healthcare professional to determine if NGS genetic testing is appropriate for an individual suspected of having nemaline myopathy type 1. They can provide more information about the testing process, its benefits, limitations, and potential implications for the individual and their family.

Test Name	TPM3 Gene Nemaline myopathy type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TPM3 Gene Nemaline myopathy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TPM3 Gene Nemaline myopathy type 1
Test Details	The TPM3 gene is associated with nemaline myopathy type 1, which is a rare genetic disorder characterized by muscle weakness and hypotonia (low muscle tone). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the TPM3 gene to identify any mutations or variations that may be causing the condition. NGS genetic testing is a highly accurate and efficient method that can simultaneously analyze multiple genes, including the TPM3 gene, to provide a comprehensive evaluation of the genetic basis of nemaline myopathy type 1. This type of testing can help confirm a diagnosis, identify specific genetic mutations, and inform treatment and management options. It is important to consult with a genetic counselor or healthcare professional to determine if NGS genetic testing is appropriate for an individual suspected of having nemaline myopathy type 1. They can provide more information about the testing process, its benefits, limitations, and potential implications for the individual and their family.